IP Library › Assignment 059358/0700
Patent Assignment
Reel/Frame 059358/0700

Reassignment and Release of Security Interest

Recorded: 2022-03-10 Pages: 14
Assignor
OXFORD FINANCE LLC
Executed: 2022-03-08
Assignee
XERIS PHARMACEUTICALS, INC.
180 NORTH LASALLE STREET, SUITE 1600, CHICAGO, ILLINOIS, 60601
Covered Properties (21)
Intracutaneous Injection
Patent: 8,110,209 →
Application: 10/539,931 →
Publication: US 2006/0211982
Intracutaneous Paste Composition
Patent: 8,790,679 →
Application: 12/946,994 →
Publication: US 2011/0060310
Stable Formulations for Parenteral Injection of Peptide Drugs
Patent: 8,697,644 →
Application: 13/417,073 →
Publication: US 2012/0232001
Methods for Rapidly Treating Severe Hypoglycemia
Patent: 9,018,162 →
Application: 13/826,662 →
Publication: US 2014/0221288
Stable Formulations for Parenteral Injection of Small Molecule Drugs
Patent: 9,125,805 →
Application: 13/829,937 →
Publication: US 2014/0005135
Stable Formulations for Parenteral Injection of Peptide Drugs
Patent: 9,302,010 →
Application: 14/188,464 →
Publication: US 2014/0171362
Stable Formulations for Parenteral Injection of Peptide Drugs
Patent: 9,295,724 →
Application: 14/192,679 →
Publication: US 2014/0179599
Stable Formulations for Parenteral Injection of Peptide Drugs
Patent: 9,339,545 →
Application: 14/192,697 →
Publication: US 2014/0179600
Pastes for Injection of a Therapeutic Agent
Patent: 9,314,424 →
Application: 14/289,448 →
Publication: US 2014/0363492
Formulations for the Treatment of Diabetes
Patent: 9,138,479 →
Application: 14/354,848 →
Publication: US 2014/0349926
Compositions for Rapidly Treating Severe Hypoglycemia
Patent: 9,642,894 →
Application: 14/676,415 →
Publication: US 2015/0250855
Stable Formulations for Parenteral Injection of Small Molecule Drugs
Application: 14/812,515 →
Publication: US 2016/0151385
Stable Formulations for Parenteral Injection of Peptide Drugs
Application: 15/077,633 →
Publication: US 2017/0049858
Stable Peptide Formulations and Methods for Preparation
Application: 15/117,016 →
Publication: US 2017/0007675
Methods for Producing Stable Therapeutic Formulations in Aprotic Polar Solvents
Patent: 9,649,364 →
Application: 15/136,650 →
Publication: US 2017/0087215
Syringes, Kits, and Methods for Intracutaneous and/or Subcutaneous Injection of Pastes
Application: 15/501,333 →
Publication: US 2017/0216529
Methods for Producing Stable Therapeutic Formulations in Aprotic Polar Solvents
Application: 15/594,998 →
Publication: US 2017/0312341
Use of Low Dose Glucagon
Application: 15/735,052 →
Publication: US 2019/0083578
Methods for Producing Stable Therapeutic Glucagon Formulations in Aprotic Polar Solvents
Application: 15/763,050 →
Publication: US 2018/0271948
Precipitation Resistant Small Molecule Drug Formulations
Application: 15/994,832 →
Publication: US 2018/0369255
Stable Therapeutic Compositions in Aprotic Polar Solvents and Methods of Manufacturing the Same
Application: 62/855,134 →
Related Assignments (17)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 7, 2011
From: BGEN CORPORATION, KNOWN AS GENERIPHARM INC., A WHOLLY OWNED SUBSIDIARY OF BRESAGEN LIMITED
To: XERIS PHARMACEUTICALS INC.
Reel/Frame 025755/0655 →
Assignment of Assignor's Interest May 31, 2012
From: PRESTRELSKI, STEVEN; KINZELL, JOHN
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 028299/0946 →
Assignment of Assignor's Interest Jul 16, 2013
From: PRESTRELSKI, STEVEN J.; NEWSWANGER, BRETT
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 030802/0465 →
Assignment of Assignor's Interest Sep 26, 2013
From: PRESTRELSKI, STEVEN; SCOTT, NANCY
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 031287/0727 →
Assignment of Assignor's Interest Mar 19, 2014
From: PRESTRELSKI, STEVEN; KINZELL, JOHN
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 032478/0154 →
Assignment of Assignor's Interest Nov 18, 2014
From: PRESTRELSKI, STEVEN; SCOTT, NANCY
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 034201/0313 →
Assignment of Assignor's Interest Dec 30, 2014
From: BGEN CORPORATION, KNOWN AS GENERIPHARM INC., A WHOLLY OWNED SUBSIDIARY OF BRESAGEN LIMITED
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 034602/0298 →
Assignment of Assignor's Interest Feb 15, 2016
From: PRESTRELSKI, STEVEN; SCOTT, NANCY
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 037733/0532 →
Assignment of Assignor's Interest May 11, 2016
From: PRESTRELSKI, STEVEN; KINZELL, JOHN
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 038542/0989 →
Assignment of Assignor's Interest Jun 9, 2016
From: PRESTRELSKI, STEVEN; SANDOVAL, MICHAEL; DONOVAN, MARTIN
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 038855/0303 →
Assignment of Assignor's Interest Jan 12, 2017
From: PRESTRELSKI, STEVEN J.
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 040956/0823 →
Assignment of Assignor's Interest Oct 16, 2017
From: PRESTRELSKI, STEVEN; SANDOVAL, MICHAEL; DONOVAN, MARTIN
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 043873/0838 →
Assignment of Assignor's Interest Apr 20, 2018
From: PRESTRELSKI, STEVEN; DONOVAN, MARTIN
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 045595/0958 →
Assignment of Assignor's Interest Feb 27, 2019
From: DONOVAN, MARTIN
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 048460/0152 →
Security Interest Sep 12, 2019
From: XERIS PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 050362/0445 →
Security Interest Mar 9, 2022
From: XERIS PHARMACEUTICALS, INC.; STRONGBRIDGE DUBLIN LIMITED
To: HAYFIN SERVICES LLP
Reel/Frame 059552/0066 →
Assignment of Assignor's Interest Nov 21, 2024
From: BGEN CORPORATION, KNOWN AS GENERIPHARM INC., A WHOLLY OWNED SUBSIDIARY OF BRESAGEN LIMITED
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 069356/0461 →